English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Review article
2023
Authors:  Chang, Jane Pei Chen;  Tseng, Ping Tao;  Zeng, Bing Syuan;  Chang, Cheng Ho;  Su, Huanxing; et al.
Favorite | TC[WOS]:15 TC[Scopus]:18  IF:8.0/10.6 | Submit date：2024/01/10
Adverse Effect  Docosahexaenoic Acid (Dha)  Eicosapentaenoid Acid (Epa)  Prescription Ω-3 Pufa Products (Rxome3fas)  Tolerability  Ω-3 Polyunsaturated Fatty Acids (Pufas)  
Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials Journal article
Galling,Britta, Roldán,Alexandra, Rietschel,Liz, Hagi,Katsuhiko, Walyzada,Frozan, Zheng,Wei, Cao,Xiao Lan, Xiang,Yu Tao, Kane,John M., Correll,Christoph U.. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: Results from a systematic review and meta-analysis of randomized controlled trials[J]. Expert Opinion on Drug Safety, 2016, 15(5), 591-612.
Authors:  Galling,Britta;  Roldán,Alexandra;  Rietschel,Liz;  Hagi,Katsuhiko;  Walyzada,Frozan; et al.
Favorite | TC[WOS]:24 TC[Scopus]:28  IF:3.0/3.6 | Submit date：2021/03/02
Adverse Effects  Antipsychotics  Augmentation  Combination  Cotreatment  Metaanalysis  Monotherapy  Polypharmacy  Safety  Schizophrenia  Tolerability  
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study Journal article
Hu Y.-D., Xiang Y.-T., Fang J.-X., Zu S., Sha S., Shi H., Ungvari G.S., Correll C.U., Chiu H.F.K., Xue Y., Tian T.-F., Wu A.-S., Ma X., Wang G.. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study[J]. Psychological Medicine, 2016, 46(3), 623.
Authors:  Hu Y.-D.;  Xiang Y.-T.;  Fang J.-X.;  Zu S.;  Sha S.; et al.
Favorite | TC[WOS]:109 TC[Scopus]:117 | Submit date：2018/10/30
Escitalopram  Ketamine  Key Words Efficacy  Major Depression  Response  Tolerability